You're reading the free version. Trader adds the live tape and alerts.
Start tracking
XERS Sale Disclosure
Johnson John · SEC Form 4 · Filed Jun 5, 2026
Sale
Calculated transaction value
$91.42K
Johnson John Director
XERS
Transaction date
Jun 4, 2026
Public filing date
Jun 5, 2026
Filing lag
Filed 1 day later
XERS daily price context
Close on/before transaction
$6.15
Jun 4, 2026
First close after public filing
$6.24
Jun 8, 2026
30-day return after filing
+34.13%
Through Jul 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 15,000 shares @ $6.09
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001410781-26-000004
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$294.35K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. XERS Current | Sale | Jun 4, 2026 | $91.42K |
| Xeris Biopharma Holdings, Inc. XERS | Award | Jun 4, 2026 | $0 |
| Xeris Biopharma Holdings, Inc. XERS | Award | Jun 4, 2026 | $202.93K |